@article{7987bc66b20c4970b4f4432f97b877e6,
title = "Local therapy with an engineered oncolytic adenovirus enables antitumor response in non- injected melanoma tumors in mice treated with aPD-1",
keywords = "DELIVERY, IL-2, INNATE IMMUNITY, NECROSIS-FACTOR-ALPHA, Oncolytic adenovirus, PROMOTES, RESISTANCE, SURVIVAL, T-CELL IMMUNITY, TNFa, aPD-1, immunotherapy, lymphocytes, melanoma, 3122 Cancers, 3111 Biomedicine",
author = "Quixabeira, {Dafne C. A.} and Victor Cervera-Carrascon and Santos, {Joao M.} and Clubb, {James H. A.} and Kudling, {Tatiana V.} and Saru Basnet and Camilla Heini{\"o} and Susanna Gr{\"o}nberg-V{\"a}h{\"a}-Koskela and Marjukka Anttila and Riikka Havunen and Anna Kanerva and Akseli Hemminki",
year = "2022",
month = jan,
day = "22",
doi = "10.1080/2162402X.2022.2028960",
language = "English",
volume = "11",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "TAYLOR & FRANCIS INC",
number = "1",
}